Rat Model Market 2021-2025 by top trends, outlook & growth forecast

Delaware, U.S. – Rising necessity to develop advanced vaccines is a major factor driving the growth of the rat model market. Rat models are basically used to analyze the occurrences and development of diseases as these animals and humans have various functional resemblances. Rats are also used as mechanistic studies of human reproduction. Thus, increasing number of testing procedures on rats to ensure safe use of drugs in humans is aiding the expansion of rat model industry outlook.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/4165

Growing inclination towards the use of rats to conduct cognitive research studies pertaining to cancer, cardiovascular diseases and autoimmune diseases is contributing to the growth of the rat model industry. Estimates claim that rat model market will be worth USD 1.8 billion by the year 2025. Escalating consumption rates of personalized medicines and myriad applications of rat models in drug discovery are also augmenting the product demand in various biotechnology centers across the globe.

Based on rat type, the rat model market is categorized into hybrid, knockout, outbred and inbred rats in which the inbred rat model segment held the 25% share in the market in 2018. Rat models can simulate autoimmune diseases which can affect humans and can provide more tissue samples as compared to mice models. This further facilitates researchers to understand disease mechanism in the body. Increasing usage of rat models in autoimmune disease research is thus driving the growth of the segment.

Speaking of technology, the rat model market is classified into microinjection, CRISPR, nuclear transfer and embryonic stem cell. The CRISPR rat model technology held 31.5% of the overall market share in the year 2018. CRISPR technology is used to alter target genes and offers benefits such as cost-effectiveness, ease of use, better efficiency and time-saving. Rising demand of CRISPR technology in various biotechnology centers is thus boosting the segmental growth.

Elaborating on application spectrum, the rat model market is bifurcated into production, quality control, research & development and academics. Notably, the research & development segment held the largest share of 72.2% in 2018 owing to surging need of rat models in R&D activities. In terms of use, the rat model is divided into veterinary and human use. Rising rat testing procedures performed to understand diabetes, cardiovascular diseases, cancer, and autoimmune diseases that can harm humans is contributing to the growth of the human use segment. The human use segment held the largest share of 80% in rat model market in 2018.

As per end-use, the rat model industry is divided into organizations, academic & research institutes, contract research organizations and companies. Companies segment held 61.2% share in rat model market in 2018. Development of advanced vaccines in tandem with increasing number of R&D activities in pharma and biotech industries for analyzing safety and efficacy of drugs in humans is aiding the rat model market expansion.

Considering the geographical landscape, the U.S rat model market is expected to grow with a CAGR of 8% during the period of 2019-2025. According to the American Burn Association, about 486,000 people have been reported for burn / fire injuries in emergency departments. On this account, various research companies across the country are primarily focusing on performing physiological tests which humans and rats share in order to replicate the skin structure of humans.

Request for Customization @ https://www.gminsights.com/roc/4165

The prominent companies operating in the rat model market are genOway, Envigo, Horizon Discovery Group Plc, Charles River, Transviragen Inc., Biomere, Taconic Biosciences Inc., Transpogen Biopharmaceutical Inc. and Taconic Biosciences. These key players are primarily focusing on conducting various business strategies such as mergers and acquisitions in order to capitalize on the changing genome industry trends. In April 2019 for instance, Charles River Laboratories purchased Citoxlab to expand its scientific product profile and improve client partner relations.

Related News – https://www.marketwatch.com/press-release/hair-transplant-market-2021-key-trends-opportunities-forecasts-to-2026-2021-11-23

https://www.marketwatch.com/press-release/geriatric-care-services-market-2021-2027-by-trends-outlook-growth-forecast-2021-11-23

https://www.marketwatch.com/press-release/electronic-health-record-market-by-regional-growth-trend-and-industry-outlook-2021-2027-2021-11-23

 

Leave a comment

Your email address will not be published. Required fields are marked *